GlaxoSmithKline (Cambodia) Co., Ltd, in partnership with the Ministry of Health, is dedicated to improving quality of life in Cambodia. GSK first started operating in Cambodia in 1997 via local distributors. In 2013 we set up a local legal entity based in Phnom Penh as part of our long-term commitment to this vibrant country. We enable people to do more feel better and live longer, regardless of where they live or their ability to pay.
GSK Cambodia is part of GSK’s Africa & Developing Countries Asia unit. The unit (previously called Developing Countries and Market Access (DCMA)) was set up in 2010 to bring a dedicated focus to our operations in developing countries, encompassing all Least Developed Countries (LDC). The unit aims to increase the availability and accessibility of GSK medicines and vaccines in developing countries in a way that is sustainable. The price of patented medicines is capped at no more than 25% of prices in developed countries. We reinvest 20% of the profits we make in LDCs back into projects that strengthen healthcare infrastructure in these countries. Globally, GSK works in partnership with other companies, governments, international agencies and academic institutions, NGOs and communities in this effort.